Literature DB >> 9237722

Lymphocyte reactivity to hepatitis C virus (HCV) antigens shows evidence for exposure to HCV in HCV-seronegative spouses of HCV-infected patients.

J P Bronowicki1, D Vetter, G Uhl, H Hudziak, A Uhrlacher, J M Vetter, M Doffoel.   

Abstract

Lymphocyte reactivity against hepatitis C virus (HCV) antigens was studied in 20 couples in which 1 member had chronic hepatitis C. This was done to investigate the possibility of HCV transmission between spouses that was not followed by seroconversion. Twenty healthy subjects without any risk factors for HCV transmission served as negative controls. All the patients' spouses and the healthy controls were negative for HCV RNA and for anti-HCV antibody. Lymphocytes were cultured with recombinant HCV core and nonstructural antigens (c22, c33, c100, c200, and NS5) and with control antigens (sperm whale myoglobin, chicken lysozyme, and superoxide dismutase). Lymphocytes from 10 patients and 4 seronegative spouses proliferated in the presence of at least one HCV antigen. No proliferation was shown with nonspecific antigens or in the control group. This study gives evidence for possible in vivo priming with HCV antigens that did not lead to seroconversion in spouses of HCV-positive patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9237722     DOI: 10.1086/517279

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Development of a primary tamarin hepatocyte culture system for GB virus-B: a surrogate model for hepatitis C virus.

Authors:  B Beames; D Chavez; B Guerra; L Notvall; K M Brasky; R E Lanford
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees.

Authors:  Mohamed Tarek Shata; Nancy Tricoche; Marion Perkus; Darley Tom; Betsy Brotman; Patricia McCormack; Wolfram Pfahler; Dong-Hun Lee; Leslie H Tobler; Michael Busch; Alfred M Prince
Journal:  Virology       Date:  2003-09-30       Impact factor: 3.616

3.  Effect of bottlenecking on evolution of the nonstructural protein 3 gene of hepatitis C virus during sexually transmitted acute resolving infection.

Authors:  Josep Quer; Juan Ignacio Esteban; Joan Cos; Sílvia Sauleda; Laura Ocaña; María Martell; Teresa Otero; Maria Cubero; Eduard Palou; Pedro Murillo; Rafael Esteban; Jaume Guàrdia
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Statistical linkage analysis of substitutions in patient-derived sequences of genotype 1a hepatitis C virus nonstructural protein 3 exposes targets for immunogen design.

Authors:  Ahmed A Quadeer; Raymond H Y Louie; Karthik Shekhar; Arup K Chakraborty; I-Ming Hsing; Matthew R McKay
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

5.  Immunological and PCR analyses for Borna disease virus in psychiatric patients and blood donors in Japan.

Authors:  K Fukuda; K Takahashi; Y Iwata; N Mori; K Gonda; T Ogawa; K Osonoe; M Sato; S Ogata; T Horimoto; T Sawada; M Tashiro; K Yamaguchi; S Niwa; S Shigeta
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

6.  Strong hepatitis C virus (HCV)-specific cell-mediated immune responses in the absence of viremia or antibodies among uninfected siblings of HCV chronically infected children.

Authors:  Mohamed Hashem; Hanaa El-Karaksy; Mohamed T Shata; Maha Sobhy; Heba Helmy; Suzan El-Naghi; Gehan Galal; Zainab Z Ali; Gamal Esmat; Sayed F Abdelwahab; G Thomas Strickland; Samer S El-Kamary
Journal:  J Infect Dis       Date:  2011-01-21       Impact factor: 5.226

7.  Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients.

Authors:  Sanaa M Kamal; Ashraf Amin; Mohamed Madwar; Camilla S Graham; Qi He; Ahmed Al Tawil; Jens Rasenack; Tatsunori Nakano; Betty Robertson; Alaa Ismail; Margaret James Koziel
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

8.  Hepatitis C virus-specific immune responses in noninjecting drug users.

Authors:  M Zeremski; J Makeyeva; K Arasteh; D C Des Jarlais; A H Talal
Journal:  J Viral Hepat       Date:  2012-02-22       Impact factor: 3.728

9.  Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV.

Authors:  Eishiro Mizukoshi; Christoph Eisenbach; Brian R Edlin; Kimberly P Newton; Sukanya Raghuraman; Christina Weiler-Normann; Leslie H Tobler; Michael P Busch; Mary Carrington; Jane A McKeating; Thomas R O'Brien; Barbara Rehermann
Journal:  J Infect Dis       Date:  2008-07-15       Impact factor: 5.226

10.  Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users.

Authors:  M Zeremski; M A Shu; Q Brown; Y Wu; D C Des Jarlais; M P Busch; A H Talal; B R Edlin
Journal:  J Viral Hepat       Date:  2008-07-17       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.